Lebenslauf

Privat:

Blumenthalstr. 2
14163 Berlin
Tel 030-805 88 196

• Deutsche Gesellschaft für Medizinische Psychologie
• Deutsche Gesellschaft für Psychologie
• European Neuroscience Association
• International Brain Research Organization (IBRO)
• Society for Neuroscience (USA)
• International Society for Neurochemistry
• Controlled Release Society
• Deutscher Hochschulverband

Herausgeberschaften

• Editor-in-Chief der Zeitschrift RESTORATIVE NEUROLOGY AND NEUROSCIENCE  (IOS Press, The Netherlands); gelistet in medline, current contents, und andere Referenzdiensten; bisher 23 volumes.
• JOURNAL OF NEUROTRAUMA; Mitglied Editorial Board.
• ZEITSCHRIFT FÜR MEDIZINISCHE PSYCHOLOGIE; Mitglied des wissenschaftlichen Beirats.

Begutachtungserfahrung

• Israel Science Foundation
• Land Sachsen-Anhalt
• Universität Magdeburg
• Deutsche Forschungsgemeinschaft (DFG)
• Raine Foundation, Australia
• BMBF

Auszeichnungen

• Leonardo da Vinci award; The World Organization for the Achievement of Human Potential, Philadelphia, 2005
• Maria Saveria Cinquegrani -Preis des Verbundes der Innovation Relay Centers  (IRC) der Europäischen Gemeinschaft für die beste Innovation in Communication and Information Technologies, Florenz, 2000
• Zitierung in "Who´s Who in Science and Engineering" 1993-2001
• Zitierung in "Who´s Who in the World" 1990-2001
• Followship der International Society for Eye Research, 1992
• Clark University Exchange Scholar, 1978-80.
• Stipendiat der FULBRIGHT KOMMISSION, 1978-80
• Stipendiat des DAAD, 1982-84
• Research Fellow, The Graduate School, Clark University, 1983-1984
• Wettbewerb "JUGEND FORSCHT", Sonderpreis Rheinland-Pfalz, 1976

Lehre

Umfangreiche Lehrerfahrung mit Biologie- und Psychologie-Studenten an der Clark University und am Massachusetts Institute of Technology; sowie mit Medizin- und Psychologie-Studenten an der Universität München und an der Universität Magdeburg.

• Hauptvorlesung "Grundlagen der Neurowissenschaften", Uni. Magdeburg, 1997-2000
• Hauptvorlesung "Biologische Psychologie", Uni. Magdeburg, 1997-2000
• Doktorandenkolloquium, Uni. Magdeburg (seit 1992)
• Seminar zur Med. Psychol., Uni. Magdeburg (seit 1992)
• Hauptvorlesung in  Med. Psychol., Uni. Magdeburg, jeweils WS (seit 1992)
• Hauptvorlesung in Med. Psychol., Uni. München, (mit Prof. Pöppel), 1988-1992
• Seminar zur Med. Psychol., Uni. München, 1987-1992
• Doktorandenseminar,  Uni. München, (mit Prof. Pöppel) 1987-1992
• Functional Neuroanatomy, Clark University, Frühjahr 1986
• Neuroscience and Behavior, M.I.T., Herbst 1984 (mit Prof. Schneider)
• Introduction to Neuroanatomy, Clark University, Herbst 1982

Lehrassistenz während des Promotionsstudiums an der Clark University: 

• PSYCH 302 Graduate Statistics, WS 1982, Clark University (Statistik)
• PSYCH 297 Directed Research, WS 1982, Clark University
• PSYCH 298 Directed Readings, WS 1983, Clark University
• PSYCH 219 Research in Brain Damage & Behavior, SS 1984, Clark University
• PSYCH 101 General Psychology, SS 1983, Clark University
• PSYCH 302 Graduate Statistics, WS/SS 1983-84, Clark University

Erfahrungen in der Hochschulselbstverwaltung

1. Mitglied in Berufungskommissionen:
    - "Psychiatrie" (Vorsitz),
    - "Pharmakologie/Toxikologie" (Vorsitz),
    - "Physiologie",
    - "Physiologie Spezialgebiet",
    - "Neurologie",
    - "klinische Neurophysiologie (Neurologie II)",
    - "Entwicklungspsychologie", "Neuroanatomie",
    - "Kinder- und Jugendpsychiatrie",
    - "Psychosomatik",
    - "Methodenlehre in der Psychologie",
    - "Sozialpsychologie",
    - "Allgemeine Psychologie I",
    - "Neuropsychologie",
    - "Biologische Psychologie"

2. Andere Hochschulgremien:  Mitglied in der Senatskommission "Einrichtung Studiengang Psychologie/Biologie", Initiator des Studienganges Psychologie an der Universität Magdeburg, Mitglied der Forschungskommission Medizin (1994-2004), Mitglied des Fakultätsrats Medizin (1993-1998), Mitglied des Senats derOtto-v.-Guericke Universität Magdeburg, 2002-2004.

3. Vorstandsmitglied des Graduiertenkollegs "Biologische Grundlagen von Erkrankungen des Nervensystems" (1995-2003).

4. Sprecher, BMBF-Verbundprojektes Magdeburg/Berlin "Neurotraumatologie und neuropsychologische Rehabilitation" (1994-2000).

5. Vorsitzender des Wissenschaftlichen Beirats und Aufsichtsratmitglied; "Zentrum für Neurowissenschaftliche Innovation und Technologie (ZENIT)" (1994-1998).

6. Beauftragter für Auslandsangelegenheiten der Medizinischen Fakultät, 1992-1994.

Kongress-Organisationen

1.  "Neuroscience in Germany", Social event held in conjunction with the American Society for Neuroscience as follows:  Miami Beach 1994, San Diego 1995, Washington 1996, New Orleans 1997, Miami Beach 1999, Anaheim 2000, San Diego 2001,Orlando 2002, New Orleans 2003, San Diego 2004, Washington 2005, Atlanta 2006. 
   
2.  "Restoration of Vision after Brain Damage",  Symposium  as part of the "VISION 2005" meeting in London; Royal National Institute of the Blind (RNIB). (together with Torsten Wiesel, Nobel Laureate), London, 2005.    

3. "Aging and Communication", Congress of the German American Academic Council (GAAC), organized at the University of Michigan, Ann Arbor, May 1999, together     with D. Park and N. Charness.

4. "Neurotrauma and Plasticity", Congress of the German BMBF-research initiative, Magdeburg, Germany, 1999.

5. "Visual system damage: residual function and plasticity", technical workshop im Rahmen des "Forum of European Neuroscience", Juli 1998.

6. "Visual System Plasticity and Rehabilitation",  Symposium im Rahmen des "6th International Congress on Research in Rehabiliation", Juni 1998.

7. "Plasticity after lesion to the visual system",  Symposium bei der European Winter Brain Research Conference in Les Arcs, Frankreich,  zusammen mit G.    
    Innocenti, March 1998.

8. "Brain Plasticity", a satellite Symposium of the Conference "BRAIN 1995", Düsseldorf, 1995, zusammen mit H.J. Freund und O. Witte.

9. "10th Congress of the German Society for Medical Psychology", Magdeburg, 1994, zusammen mit E. Kasten.

10. "Brain Repair", a satellite Symposium of the Annual Meeting of the European Society for Neuroscience, Wildbad-Kreuth, 1992, zusammen mit A. Björklund.

11. "Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury", Walferdange, Luxemburg, 1986, zusammen mit D.G. Stein.

Persönliches:
 
Geburtsort:             Trier
Geburtsdatum:        07.11.1957
Familienstatus:       verheiratet, 2 Kinder
Fremdsprachen:      Englisch, Französisch

Schriftenverzeichnis

A.  Veröffentlichungen in begutachteten Zeitschriften

1. Gall, C., Mueller, I., Kaufmann, C., Kasten, E. and Sabel, B.A. (2007). Long-term Stability of Partially Restored Visual Fields 3.8 Years After Vision Restoration Therapy in Stroke Patients with Visual Field Defects. submitted

2. Müller-Oehring, E., Schulte,T., Kasten, E., Müller, I., Poggel, D., Wüstenberg, T. and Sabel, B.A. (2007). Unconscious visual processing in patients with combined neglect and hemianopia. submitted

3. Bouazzaoui, A., Kubasch, J., Radunz, H.E. and Sabel, B.A. (2007). Development of PBCA nanoparticles as DNA Carrier System for non-viral Gene Therapy. submitted

4. Gudlin, J., Mueller, I., Thanos, S. and Sabel, B.A. (2007). Vision Restoration Therapy (VRT) in glaucoma - a small open study. submitted

5. Paramei, G.V. and Sabel, B.A. (2007). Gestalt perception deficits in the intact field of hemianopic patients. submitted

6. Schneider, T., Becker A., Ringe, K., Firsching R, and Sabel, B.A. (2007). Brain tumour treatment with combined vaccination and antisense -oligonucleotide-delivery using nanoparticles. submitted

7. Mueller, I., Mast, H. and Sabel, B.A. (2007). Recovery of visual function after brain injury: a large-sample study using Vision Restoration Therapy. submitted

8. Poggel, D.A., Kasten, E., Bunzenthal, U., Müller-Oehring and Sabel, B.A. (2007). Topographical patterns of visual field recovery: changes of visual field size and its subjective representation in brain-lesioned patients during vision restoration therapy. submitted

9. Jobke, S., Kasten, E., Methling, D. and Sabel B.A. (2007). Influence of uncorrected ametropia on computer-based perimetry in patients with visual field defects and normal subjects. submitted

10. Prilloff, S., Noblejas, M.I., Chedhomme, V.and Sabel, B.A. (2007). The dual role of calcium activation after neurotrauma: life or death of retinal ganglion cells in vivo depends on calcium dynamics after optic nerve crush. European Journal of Neuroscience in press

11. Poggel, D.A., Müller-Oehring, E.M., Gothe, J., Kenkel, S., Kasten, E. and Sabel, B.A. (2007). Visual hallucinations as a hallmark of brain plasticity during spontaneous and training-induced recovery of visual functions. Neuropsychologia in press

12. Kasten, E., Bunzenthal, U., Müller-Oehring, E.M., Mueller, I. and Sabel, B.A. (2007). Vision restoration therapy does not benefit from  co-stimulation in patients with visual field defects. Journal of Experimental and Clinical Neuropsychology in press

13. Poggel, D.A., Kasten, E., Müller-Oehring, E.M., Bunzenthal, U. and Sabel, B.A. (2007). Improving residual vision by attentional cueing in patients with brain lesions. Brain Research 1097: 142-148.

14. Kasten, E., Bunzenthal, U. and Sabel, B.A. (2006). Visual field recovery after vision restoration therapy (VRT) is independent of eye movements: an eye-tracker study. Behavioral Brain Research 175:18-26.

15. Tan C.S., Sabel B.A. and Eong K.G. (2006). Charles Bonnet syndrome (visual hallucinations) following enucleation. Eye 20:1394–1395.

16. Mueller I., Sabel B.A. and Kasten E. (2006). Comparison of early and late rehabilitation of stroke and cerebral trauma patients with visual field defects. Nervenarzt 77: 694-701.

17. Sabel, B.A. (2006). Vision restoration therapy and raising red flags too early. British Journal of Ophthalmology 90[5]: 659-660.

18. Tan C.S. and Sabel B.A. (2006). Dynamic changes in visual acuity as the patho-physiologic mechanism in Charles Bonnet syndrome (visual hallucinations). European Archives of Psychiatry and Clinical Neurosciences 256: 62-63.

19. Tan C.S., Sabel B.A. and Goh K.Y. (2006). Visual hallucinations during visual recovery after central retinal artery occlusion. Archives of Neurology 63: 598-600.

20. D.A. Poggel, E. Kasten, E.M. Müller-Oehring, U. Bunzenthal and B.A. Sabel (2005). Verbesserung residualer Sehfähigkeit bei Patienten mit homonymen Gesichtsfeldausfällen durch räumliche Aufmerksamkeit. Zeitschrift für Medizinische Psychologie 14: 119-139.

21. Tan C.S. and Sabel B.A. (2005). Charles Bonnet syndrome after occipital cortical resection for cortical dysplasia may be related to denervation supersensitivity? Archives of Neurology 62: 1479.

22. Tan C.S. and Sabel B.A. (2005). Charles Bonnet syndrome in patients with visual field defects--are hallucinations good or bad? Journal of Neurosurgery 103: 193-195.

23. Kasten, E. and Sabel, B.A. (2005). Beurteilung und Verbesserung pathologischer Stimmen.  Zeitschrift für Medizinische Psychologie 14: 83-90.

24. Sabel, B.A. and Trauzettel-Klosinski, S. (2005). Improving vision in a patient with homonymous hemianopia.  Journal of Neuroophthalmology 25: 143-149.

25. Sabel, B.A., Kenkel, S. and Kasten, E. (2005). Vision restoration therapy: expanding our view. British Journal of Ophthalmology 89: 522-524.

26. Reinhard, J., Schreiber, A., Schiefer, U, Kasten, E., Sabel, B.A., Kenkel,  S., Vonthein,  R. and Trauzettel-Klosinski, S. (2005). Does visual restitution training change absolute homonymous visual field defect? A fundus-controlled study. British Journal of Ophthalmology 89: 30-35.

27. Sabel, B.A., Kenkel, S. and Kasten, E. (2004). Vision restoration therapy (VRT) efficacy as assessed by comparative perimetric analysis and subjective questionnaires. Restorative Neurology and Neuroscience 22: 399-420.

28. Poggel, D.A., Kasten E and Sabel , B.A. (2004). Attentional cueing improves vision restoration therapy in patients with visual field loss. Neurology 63: 2069-2076.

29. Wüst, S., Kasten, E., and Sabel, B.A. (2004). Visuelles Restitutionstraining nach Schädigung des Nervus opticus. Zeitschrift für Medizinische Psychologie 13: 131-141.

30. Hanke, J. and Sabel B.A. (2004). L-type channel antagonist nifedipine reduce neuro-filament restitution following traumatic optic nerve injury. Acta Neurochirurgica Suppl. 89: 75-80.

31. Kreutz M.R., Weise J., Dieterich D.C., Kreutz M., Balczarek P., Bockers T.M., Wittkowski W., Gundelfinger E.D. and Sabel B.A. (2004). Rearrangement of the retino-collicular projection after partial optic nerve crush in the adult rat. European Journal of Neuroscience 19: 247-257.

32. Mueller, I, Poggel, D.A., Kenkel, S., Kasten, E. and Sabel, B.A.  (2003). Vision Restoration Therapy (VRT) after brain damage: subjective improvements of activities of daily life and their relationship to visual field enlargements. Visual Impairment Research 5: 157-178.

33. Ringe, K., Walz, C.M. and Sabel, B.A. (2003). Nanoparticle Drug Delivery To The Brain. Encyclopedia of Nanoscience and Nanotechnology (N. Nalva, Ed.)

34. Kuelzow, N., Mueller, I. and Sabel B. (2003). Reaction times and probability of stimulus detection in areas of residual vision after brain damage. In B. Berglund and E. Borg (Ed.), Fechner Day 2003. Proceedings of the nineteenth annual meeting of the International Society for Psychophysics (pp. 145-150). Stockholm: International Society for Psychophysics.

35. Kasten, E. and Sabel, B.A. (2003). Plastizität des visuellen Systems. Neurologische Rehabilitation 9: 113-123.

36. Rohatgi, T., Sedehizade, F., Sabel, B.A. and G. Reiser. (2003). Protease-activated receptor (PAR) subtype expression in developing rat eye and in adult retina, following optic nerve crush. Journal of Neuroscience Research 73: 246-254.

37. Mueller-Oehring, E.M., Kasten, E., Poggel, D.A., Schulte, T., Strasburger, H. and Sabel, B.A. (2003). Neglect and hemianopia superimposed. Journal of Clinical and Experimental Neuropsychology 25: 1154-1168.

38. Gothe, J., Brandt, S.A., Irlbacher, K., Röricht, S., Sabel, B.A. and Meyer, B.-U. (2002).  Changes in visual cortex excitability in blind subjects as demonstrated by transcranial magnetic stimulation. Brain 125: 479-490.

39. Schulte, T., Warzel, H., Westphal, S., Müller-Oehring, E.M., Strasburger, H., Dierkes, J. and Sabel, B.A. (2002). The acute effect of moderate alcohol consumption on cardiovascular responses in healthy males with different tolerance-levels. Neuropsychobiology 45: 191-198.

40. Wüst, S., Kasten, E. and Sabel, B.A. (2002). Blindsight after optic nerve injury indicates functionality of spared fibers. Journal of Cognitive Neuroscience 14: 243-253.

41. Schulte, T., Warzel, H., Strasburger, H. and Sabel, B.A. (2001). Deficits of respiratory-cardiac coupling in heavy drinkers. Progress in neuro-psychopharmacology & biological psychiatry 25: 1241-1256.

42. Müller, I., Kasten, E. and Sabel, B.A. (2001). Autismus - Überblick aus neuropsychologischer Sicht unter besonderer Berücksichtigung interdisziplinärer Forschungsansätze am Beispiel der Sekretinbehandlung. Zeitschrift für Medizinische Psychologie 10: 125-136.

43. Rousseau, V. and Sabel, B.A. (2001). Restoration of vision IV: compensatory soma size increase of retinal ganglion cells predicts recovery of vision after partial optic nerve crush. Restorative Neurology and Neuroscience 18: 177-189.

44. Kasten, E., Müller-Oehring, E.M. and Sabel, B.A. (2001). Stability of visual field enlargements following computer-based restitution training - results of a follow-up. Journal of Clinical and Experimental Neuropsychology 23: 297-305.

45. Schulte, T., Müller-Oehring, E.M., Strasburger, H., Warzel, H. and Sabel, B.A. (2001). Acute effects of alcohol on divided and covert attention in men. Psychopharmacology 154: 61-69.

46. Schulte, T., Müller-Oehring, E.M. and Sabel, B.A. (2001). Der Magdeburger-Alkoholtoleranz-Test (MATT). Zeitschrift für Medizinische Psychologie 10: 69-77.

47. Poggel, D.A., Kasten, E., Müller-Oehring, E.M., Sabel, B.A. and Brandt, S.A. (2001). Unusual spontaneous and training induced visual field recovery in a patient with a gunshot lesion. Journal of Neurology, Neurosurgery and Psychiatry 70: 236-239.

48. Kasten, E. and Sabel, B.A. (2000). Läßt sich das Gesichtsfeld von Hemianopikern durch Training vergrößern: Gesichtsfeldvergrößerung bei Hemianopikern. Zeitschrift für praktische Augenheilkunde 21: 89-93.

49. Kasten, E., Poggel, D. and Sabel, B.A. (2000). Computer-based training of stimulus detection improves color and simple pattern recognition in the defective field of hemianopic subjects. Journal of Cognitive Neuroscience 12: 1-12.

50. Sabel, B.A. and Kasten E. (2000). Restoration of vision by training of residual functions. Current Opinion in Ophthalmology 11: 430-436.

51. Darius, J., Meyer, F.P., Sabel, B.A. and Schroeder, U. (2000). Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid. Journal of Pharmacy and Pharmacology 52:1043-1047.

52. Haik, K.L., Shear, D.A., Schroeder U., ,Sabel, B.A. and Dunbar, G.L. (2000). Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's Disease. Experimental Neurology 130: 430-439.

53. Schroeder, U., Schroeder, H., Schwegler, H. and Sabel, B.A. (2000). Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory. British Journal of Pharmacology 130: 33-40.

54. Keller, J., Strasburger, H., Cerutti, D.T. and Sabel, B.A. (2000). Automated assessment of the visual contrast sensitivity in the hooded rat, Journal of Neuroscience Methods 97: 103-110.

55. Sabel, B.A. and Kasten, E. (2000). Restoration of vision in persons with brain injury. Brain Injury Source 4: 12-16.

56. Harder, A., Kasten, E., and Sabel, B.A. (2000). Möglichkeiten der Mobilität blinder Menschen.  Aktuelle Augenheilkunde 215: 7-12.

57. Sommerfeld P., Sabel B.A., and Schroeder U. (2000). Long-term stability of PBCA nanoparticle suspensions. Journal of Microencapsulation 17: 69-79.

58. Schroeder, U., Schroeder H. and B.A. Sabel (1999). Body distribution of 3H-labelled dalargin bound to butyl-cyanoacrylate nanoparticles after i.v. injections to mice. Life Sciences 66: 495-502.

59. Sabel, B.A. (1999). Residual vision and plasticity after visual system damage. Restorative Neurology and Neuroscience 15: 73-79.

60. Kasten, E., Gothe, J., Bunzenthal, U. and Sabel, B.A. (1999). Kampimetrische Untersuchung visueller Funktionen am Computermonitor. Zeitschrift für Psychologie 207: 97-118.

61. Arndt, M., Bank, U., Frank, K., Sabel, B.A., Ansorge, S. and Lendeckel, U. (1999). R-esp1, a rat homologue of Drosophila Groucho, is differentially expressed after optic nerve crush and mediates NGF-induced survival of PC12 cells. FEBS Letters 457: 246-250.

62. Ehrhardt, J., Sabel, B.A., and Schroeder, U. (1999). Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats. European Neuropsychopharmacology 10: 69-74.

63. Schroeder, U., Sabel, B.  and Schroeder, H. (1999). Diffusion enhancement of drugs by loaded nanoparticles in vitro. Prog. Neuro-Psychopharmacology & Biological Psychiatry 23: 941-949.

64. Rousseau, V., Engelmann, R., and Sabel, B.A. (1999). Restoration of vision III: soma swelling dynamics predicts neuronal death or survival after optic nerve crush in vivo.  NeuroReport 10: 3387-3391.

65. Kasten, E., Poggel, D.A., Müller-Oehring, E., Gothe, J., Schulte, T. and Sabel, B.A. (1999). Restoration of vision II: residual  functions and training-induced restitution in hemianopic patients.  Restorative Neurology and Neuroscience 15: 273-287.

66. Sabel, B.A. (1999). Restoration of vision I:  Neurobiological mechanisms of restoration and plasticity after brain damage - a review. Restorative Neurology and Neuroscience 15: 177-200.

67. Kasten, E., Poggel, D.A., Gothe, J., Müller-Oehring, E. and Sabel, B.A. (1999). Ambulante neuropsychologische Therapie von Patienten mit Hirnschäden. Report Psychologie 24: 194-216.

68. Kreutz MR, Bien A, Vorwerk CK, Bockers TM, Seidenbecher CI, Tischmeyer W. and Sabel BA. (1999) Co-expression of c-Jun and ATF-2 characterizes the surviving retinal ganglion cells which maintain axonal connections after partial optic nerve injury. Brain Research., Molecular Brain Research 69: 232-241.

69. Vorwerk, C.K., Kreutz, M.R., Böckers, T.M., Brosz, M. Dreyer E.B. and Sabel, B.A. (1999). Susceptibility of retinal ganglion cells to excitotoxicity depends on soma size and retinal eccentricity, Current Eye Research 19: 59-65.

70. Kreutz, M.R., Seidenbecher, C.I., and Sabel, B.A. (1999). Molecular plasticity of retinal ganglion cells after partial optic nerve injury. Restorative Neurology and Neuroscience 14: 127-134.

71. Schulte, T., Strasburger, H., Müller-Oehring, E.M., Kasten, E., and Sabel, B.A. (1999). Automobile driving performance of brain-injured patients with visual field defects. American Journal of Physical Medicine & Rehabilitation 78: 136-142.

72. Bien, A., Seidenbecher, C.I., Böckers, T.M., Sabel, B.A. and Kreutz, M.R. (1999). Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury. Journal of Neurotrauma 16: 153-163.

73. Kasten, E., Wüst, S. and Sabel, B.A. (1998). Residual vision in transition zones in patients with cerebral blindness. Journal of Clinical and Experimental Neuropsychology 20: 581-598.

74. Kasten, E., Wuest. S. and Sabel, B.A. (1998). Variability of stimulus detection, form discrimination, and color recognition with suprathreshold campimetry in brain damaged patients. Neuro-Ophthalmology 20: 161-176.

75. Schmitt, U., Sabel B.A., Cross, R., Samson. F.E. and Pazdernik, T.L. (1998). Recovery of metabolic activity in retinofugal targets after traumatic optic nerve injury is independent of retinofugal input. Restorative Neurology and Neuroscience 13: 153-161.

76. Kreutz, M.R., Böckers, T.M., Bockmann, J., Seidenbecher, C., Kracht, B., Vorwerk, C.K., Weise, J. and Sabel, B.A. (1998). Splicing of the retinal NR1 receptor is altered after optic nerve injury:  the preferential expression of the NR1-b isoforms is crucial for retinal ganglion cell survival. Journal of Neuroscience 18: 8278-8291.

77. Schroeder, U., Sommerfeld, P., Ulrich, S. and Sabel, B.A. (1998). Nanoparticle technology for drug delivery across the blood brain barrier. Journal of Pharmaceutical Sciences 87: 1305-1307.

78. Seidenbecher, C.I., Langnaese, K., Sanmarti-Vila, L., Boeckers, T.M., Smalla, K.H., Sabel, B.A., Garner, C.C., Gundelfinger, E.D. and Kreutz, M.R. (1998). Caldendrin, a novel neuronal calcium-binding protein confined to the somato-dendritic compartment. Journal of Biological Chemistry 273: 21324-21331.

79. Kasten, E., Wüst, S., Behrens-Baumann, W. and Sabel, B.A. (1998). Computer-based training for the treatment of partial blindness. Nature medicine 4:1083-1087.

80. Schroeder, U.,  Sommerfeld, P. and Sabel, B.A. (1998). Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides 19: 777-780.

81. Sommerfeld, P., Schroeder U. and Sabel, B.A. (1998). Sterilization of unloaded polybutyl-cyanoacrylate nanoparticles. International Journal of Pharmaceutics 164: 113-118.

82. Haik-Creguer, K.L., Dunbar, G., Sabel, B.A. and Schroeder U. (1998). Small drug sample fabrication of controlled release polymers using the microextrusion method. Journal of Neuroscience Methods 80: 37-40.

83. Kasten, E., Müller-Oehring, E., Poggel, D. and Sabel, B.A. (1998). Chronic visual hallucinations and illusions following brain damage. Fortschritte der Neurologie-Psychiatrie 66: 49-58.

84. Schroeder, U., Schroeder, H., Darius, J., Greksch, G. and Sabel, B.A. (1998). Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behavioral Brain Research 97: 59-68.

85. Schröder, H., Schröder, U., and Sabel, B.A. (1997). The role of striatal glutamatergic system in haloperidol-induced dopamine receptor supersensitivity and effects of monosialoganglioside GM1. Pharmacology, Biochemistry and Behavior 58: 903-907.

86. Greksch, G., Zhou, D., Franke, C., Schroeder, U., Sabel, B.A., Becker, A. und Huether, G. (1997).  Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptamine presynapses in the rat frontal cortex:   behavioural correlates. British Journal of Pharmacology 122: 1725-1731.

87. Sommerfeld, P., Schroeder, U. and Sabel, B.A. (1997). Long-term stability of PBCA nanoparticle suspension suggests clinical usefulness.  International Journal of Pharmaceutics 155: 201-207.

88. Kasten, E., Bielau, H., Glanz, W. and Sabel, B.A. (1997). Auswirkung der Kosteneinsparung im Gesundheitswesen auf das Arzt-Patient-Verhältnis. Zeitschrift für Medizinische Psychologie 6: 38-44.

89. Sabel, B.A. (1997). Unrecognized potential of surviving neurons:  Within-systems plasticity, recovery of function and the hypothesis of the minimal residual structure. The Neuroscientist 3: 366-370.

90. Kreutz, M.R., Böckers, T.M., Sabel, B.A., Hülser, E., Stricker, R. and Reiser, G. (1997). Expression and subcellular localization of a neuronal Ins 1,3,4,5-P4 binding protein in the rat central nervous system. European Journal of Neuroscience 9: 2110-2124.

91. Kasten, E., Schulte, T. and Sabel, B.A. (1997). Fahrtauglichkeit und Fahrpraxis bei Personen mit erworbener Gesichtsfeldeinschränkung.  Zeitschrift für Verkehrssicherheit 43: 116-122.

92. Kasten, E., Strasburger, H. and Sabel, B.A. (1997). Programs for diagnosis and therapy of visual field deficits in visual rehabilitation. Spatial Vision 10: 499-503.

93. Sabel, B.A., Engelmann, R. and Humphrey, M.M. (1997). In vivo confocal neuroimaging of CNS neurons (ICON). Nature medicine 3: 244-247.

94. Kreutz, M.R., Böckers, T.M., Sabel, B.A., Stricker, R., Hülser, E. and Reiser, G. (1997)  Localization of a 42 kDa inositol 1,3,4,5 tetrakisphosphate receptor protein in retina and expression after optic nerve injury. Molecular Brain Research 45: 283-293.

95. Schröder, U., Kreutz, M.R., Schröder, H and Sabel, B.A. (1997). Amphetamine induced hypermotility in MPTP-lesioned mice. Pharmcacology, Biochemistry & Behavior 56: 281-285.

96. Kasten, E., Eder, R., Robra, B.-P. and Sabel, B.A. (1997). Der Bedarf an ambulanter neuropsychologischer Behandlung.  Zeitschrift für Neuropsychologie 8:  72-85.

97. Sabel, B.A., Kasten E.,  Kreutz, M.R. (1997). Recovery of vision after partial visual system injury as a model of post-lesion neuroplasticity. Advances in Neurology 73: 251-276.

98. Schmitt, U. and Sabel, B.A. (1996). MK-801 increases retinal ganglion cell death but reduces visual deficits after controlled optic nerve crush. Journal of Neurotrauma 13: 791-800.

99. Vorwerk, C.K., Lipton, S.A., Zurakowski, D.,  Hyman, B.T., Sabel, B.A. and Dreyer, E.B. (1996). Chronic low dose glutamate is toxic to retinal ganglion cells; toxicity blocked by memantine. Investigative Ophthalmology and Visual Science 37: 1618-1624.

100. Vorwerk, C.K., Kreutz, M.R., Dreyer, E.B. and Sabel, B.A. (1996). Systemic L-kynurenine administration partially protects against NMDA but not kianate induced degeneration of retinal ganglion cells and reduces brightness discrimination deficits in adult rats.  Investigative Opthalmology and Visual Science 37: 2382-2392.

101. Schild, L., Westphal, S., Scheithauer, S., Holfeld, M., Augustin, W. and Sabel, B.A. (1996).  Isolation of functionally intact pig retina mitochondria.  Acta Ophtalmologica Scandinavica 74: 354-357.

102. Schmitt, U. and Sabel, B.A. (1996). Basic fibroblast growth factor treatment protects from visual deficits but does not increase retinal ganglion cell survival following controlled optic nerve crush. Restorative Neurology and Neuroscience 10: 61-68.

103. Bockmann, J., Böckers, T.M., Vennemann, B., Niklowitz, P., Müller, J., Wittkowski, W., Sabel, B. and M.R. Kreutz (1996). Short photoperiod-dependent down-regulation of thyrotropin-alpha and -ß in hamster pars tuberalis-specific cells is prevented by pinealectomy. Endocrinology 137: 1804-1813.

104. Schmitt, U.,  Cross, R., Pazdernik, T.L. and Sabel, B.A. (1996).  Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush in adult rats. Experimental Neurology 139: 17-24.

105. Schröder, U. and Sabel, B.A. (1996). Nanoparticles - a drug carrier system to pass the blood-brain barrier - permit central analgesic effects of i.v. dalargin injections. Brain Research 710: 121-124.

106. Böckers, T.S., Bockmann, J., Fauteck, J.D., Wittkowski, W., Sabel, B.A. and Kreutz M.R. (1996).  Evidence for gene transcription of adenohypophyseal hormones in the ovine pars tuberalis. Neuroendocrinology 63: 16-27.

107. Kasten, E. and Sabel, B.A. (1995). Fahreignung und Behinderung. Praxis Ergotherapie 8: 267- 274.

108. Sabel, B.A., Vick, A., and Höllt, V. (1995). Neurotoxic reactions of CNS cells following gene transfer with defective herpes simplex virus (HSV-1) vector. NeuroReport 6: 2447-2449.

109. Sabel, B.A., Sautter, J., Stoehr, T. and Siliprandi, R. (1995). A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA-administration in adult rats.  Experimental Brain Research 106: 93-105.

110. Kasten, E. and Sabel, B.A. (1995). Visual field enlargement after computer-training in brain damaged patients with homonymeous deficits - an open pilot trial. Restorative Neurology and Neuroscience 8: 113-127.

111. Kasten, E., Wüst, S. and Sabel, B. A. (1995). Stanley Finger: Origins of Neuroscience - A history of explorations into brain function.  Zeitschrift für Medizinische Psychologie 3: 178-180.

112. Schröder, U., Schröder, H., Augustin, W. and Sabel, B.A. (1994). Haloperidol induced behavioral supersensitivity is increased by GM1 ganglioside treatment in rats without affecting spiroperiodol binding, The Journal of Pharmacology and Experimental Therapeutics 271: 1193-1196.

113. Kasten, E., Wiegmann, U. and Sabel, B.A. (1994). Rehabilitation within the defective visual field following cerebral damage - a review.  Zeitschrift für Neuropsychologie 5: 127-150.

114. Köhler, U., Schröder, H., Augustin, W. and Sabel, B.A. (1994). A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers. Neuroscience Letters 170: 99-102.

115. Sabel, B.A. and A. Aschoff (1993). Functional recovery and morphological changes after injury to the optic nerve. Neuropsychobiology 28: 62-65.

116. Sabel, B.A. (1993). Science Reunification in Germany - "A Crash Program". Science 260: 1753-1758.

117. Sautter, J. and Sabel, B.A. (1993). Recovery of brightness discrimination in adult rats despite progressive loss of retrogradely labelled retinal ganglion cells after controlled optic nerve crush. European Journal of Neuroscience 5: 680-690.

118. Moya, K.L., Benowitz, L.I., Sabel, B.A., and Schneider, G.E. (1992). Changes in rapidly transported proteins associated with development of abnormal projections in the diencephalon. Brain Research 586: 265-272.

119. Sabel, B.A. (1992). Gangliosides and Brain Repair. Neuroscience Facts 3: 83-84.

120. Schmitt, U., Büttner, Ch. and Sabel, B.A. (1992). Die Rolle der Ganglioside in der Pharmakotherapie nach Schäden im ZNS. Münchner Medizinische Wochenschrift 134: 22-24.

121. During, M.J., Freese, A., Deutsch, A.Y., Kibat, P., Sabel, B.A., Langer, R., and Roth, R.H. (1992). Biochemical and behavioral recovery in a rodent model of Parkinson´s disease following stereotactic implantation of dopamine-containing liposomes. Experimental Neurology 115: 193-199.

122. Sautter, J. , Schwartz, M., Duvdevani, R. and Sabel, B.A. (1991). GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Research 565: 23-33.

123. Sabel, B.A., Dominiak, P., Häuser, W., During, M.J. and Freese, A. (1990). Levodopa-delivery from controlled-release polymer matrix: delivery of 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats. Journal of Pharmacology and Experimental Therapeutics 255: 914-922.

124. Ramirez, J.J. and Sabel, B.A. (1990). Towards a unified theory of ganglioside-mediated functional restoration after brain injury:  Lesion size, not lesion site, is the primary factor determining efficacy. Acta Neurobiologiae Experimentalis 50: 321-344.

125. Sabel, B.A., Dominiak, P., Häuser, W., During, M.J. and Freese, A. (1990). Extended levodopa release from a subcutaneously implanted polymer matrix in rats.  Annals of Neurology 28: 714-717.

126. Duvdevani, R., Rosner, M., Belkin, M., Sautter, J., Sabel, B.A., and Schwartz, M. (1990). Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome.  Restorative Neurology and Neuroscience 2: 31-38.

127. Sabel, B.A., Freese, A., and During, M.J. (1990). Controlled-release polymer technology as a novel approach to the treatment of Parkinson's disease. Advances in Neurology 53:  521-526.

128. Freese, A., Sabel, B.A., Saltzman, W.M., During, M.J.,  Langer, R. (1989). Controlled release of dopamine from a polymeric brain implant: in vitro characterization. Experimental Neurology 103:  234-238.

129. During, M.J., Freese, A., Sabel, B.A., Saltzman, W.M., Deutsch, A., Roth, R.H., and Langer, R. (1989). Controlled release of dopamine from a polymeric brain implant: in vivo characterization.  Annals of Neurology 25:  351-356.

130. Sabel, B.A. and Schneider G.E. (1988). The principle of "conservation of total axonal arborizations": massive compensatory sprouting in the hamster subcortical visual system after early tectal lesions. Experimental Brain Research 73:  505-518.

131. Sabel, B.A., Gottlieb, J., and Schneider G.E. (1988). Exogenous GM1 ganglioside protects against retrograde degeneration following posterior neocortex lesions in developing hamsters.  Brain Research 459: 373-380.

132. Sabel, B.A. (1988). Anatomische Kompensation nach Hirntraumen. Fortschritt der Medizin 106: 70.

133. Sabel, B.A. and Schneider, G.E. (1988).  Enhanced sprouting of retinotectal fibers after early superior colliculus lesions in hamsters treated with gangliosides. Experimental Brain Research 71: 365-376.

134. Sabel, B.A., DelMastro, R., Dunbar, G.L. and Stein, D.G. (1987). Reduction of anterograde degeneration in brain damaged rats by GM1 gangliosides. Neuroscience Letters 77: 360-366.

135. Sabel, B.A. and Stein, D.G. (1986). Pharmacological treatment of central nervous system injury. Nature 323: 493.

136. Sabel, B.A. and Schneider, G.E. (1985) Does the 'Kennard-principle' haunt Neuroscience? Comments on the Book 'Early Brain Damage, Volume 2, "Neurobiology and Behavior" edited by S. Finger and C.R. Almli. Brain Research Bulletin 16: 305-308.

137. Sabel, B.A. (1985). Treating brain injury with gangliosides.  Integrative Psychiatry 3: 199-203.

138. Sabel, B.A., Dunbar, G.L., Butler, W.M. and Stein, D.G. (1985). GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitranssection of the nigro-striatal pathway. Experimental Brain Research 60: 27-37.

139. Sabel, B.A., Labbe, R. and Stein, D.G. (1985). The saline effect: minimizing the severity of brain damage by reduction of secondary degeneration. Experimental Neurology 88: 95-107.

140. Sabel, B.A., Dunbar, G.L. and Stein, D.G. (1984). Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. Journal of Neuroscience Research 12: 429-443.

141. Sabel, B.A., Slavin, M.D. and Stein, D.G. (1984). GM1-ganglioside treatment facilitates be-havioral recovery from bilateral brain damage. Science 225: 340-342.

142. Sabel, B.A., Pritzel, M., Morgan, S. and Huston, J.P. (1984). Interhemispheric nigrothalamic projections and behavioral recovery following turning behavior induced by unilateral peripheral sensory and motor restriction. Experimental Neurology 83: 49-61.

143. Sabel, B.A., Kardon, J. and Stein, D.G. (1983). Behavioral effects of intracerebral injections of renin and captopril in intact and brain-damaged rats. Brain Research Bulletin 11: 637-642.

144. Sabel, B.A. and Stein, D. G. (1982). Intracerebral injections of isotonic saline prevent behavioral deficits from brain damage. Physiology and Behavior 28: 1017-1023.

145. Sabel, B.A. and Stein, D.G. (1981). Extensive loss of subcortical neurons in the aging rat brain. Experimental Neurology 73: 507-516.

146. Ernst, M.M., Wiertz, A. and Sabel, B.A. (1980). Sociometric choice and perception behavior in a psychodrama group of psychiatric patients. A pilot study. Sozialpsychiatrische Informationen March: 23-54 (German).

147. Sabel, B.A. (1980). Transcendental Meditation and concentration ability. Perceptual and Motor Skills 50: 799-802.

148. Sabel, B.A. (1979). Transzendentale Meditation in der Psychologie, Psychiatrie, and Psychotherapie. Medizinische Klinik 74: 1779-1784.

B. Buchbeiträge und nicht-begutachtete Übersichtsarbeiten

1. Poggel, D.A., Schulte, T., Kasten, E. and Sabel, B.A. (2001) Aging, vision and brain plasticity: restoring lost visual functions by computer-based training. In. Charness, N., Park, D.C. and Sabel, B.A. (Eds.) "Communication, Technology and Aging": Springer Publishing Corporation.

2. Poggel, D.A., Kasten, E., Müller-Oehring, E.M. & Sabel, B.A. (2000) Short-term and long-term effects of visuo-spatial attention on visual field defects in patients with cerebral lesions. Proceedings of the Summer School "Visual Attention Mechanisms", IIASS, Vietri sul Mare, Italien, 23.-28. Oktober 2000.

3. Kasten, E.,Wüst, S., Poggel, D.A., Gothe, J., Müller-Oehring, E.M., Schulte, T. and Sabel, B.A. (2000) Plastizität des visuellen Systems bei hirngeschädigten Patienten-Stand der Forschung in: Daum, I. and Widdig, W. (Eds.) Aktuelle Aspekte der Neurorehabilitation: pp. 55-74.

4.Kasten, E., Wüst, S., Poggel, D.A., Gothe, J., Müller-Oehring, E.M., Schulte, T. and Sabel, B.A. (2000) Plastizität des visuellen Systems bei hirngeschädigten Patienten - Stand der Forschung. In: Daum, I. and Widdig, W. (Eds.) "Neue Wege der Rehabilitation": Pabst Science Publishers, in press.

5. Engelmann, R. and Sabel, B.A. (1999) In vivo imaging of mammalian central nervous system neurons with the In Vivo Confocal Imaging (ICON) technique. In: "Confocal Micrscopy", Methods in Enzymology 307: pp. 563-570.

6. Kasten, E., Poggel, D.A., Gothe, J., Müller-Oehring, E.M. and Sabel, B.A. (1999) Technologieabflogenschätzung im Bereich der Neurowissenschaften. In: Bröchler, S., Simonis, G. and Sundermann, K. (eds). Handbuch Technikfolgenabschätzung: Berlin: Edition Sigma Rainer Bohn Verlag, pp. 871-889.

7. Sabel, B. A., Kasten, E., Wüst, S. (1997) Restitution visueller Funktionen: eine interdisziplinäre, neurowissenschaftliche Herausforderung. In: Mandl, H. (Eds.) Bericht über den 40. Kongreß der Deutschen Gesellschaft für Psychologie: in München 1996, pp. 348-353.

8. Kasten, E. and Sabel, B.A. (1997) Neuropsychologie, Book review of the book by Kolb B and Whishaw I.Q.. Neuroforum 2: p. 81.

9. Kasten, E., Schmielau, F., Behrens-Baumann, W., Wüst, S. and Sabel, B.A. (1997) Grundlagen der Behandelbarkeit cerebral verursachter Gesichtsfelddefekte. In: Kasten, E., Kreutz, M. R., Sabel, B.A. (Eds.) Neuropsychologie in Forschung und Praxis: Hogrefe, Göttingen, pp. 165-186.

10. Schroeder, U., Schroeder, H. and Sabel, B.A. (1997) Glutamat-Dopamin-Interaktion und ihre Stoerungen im zentralen Nervensystem - Neue Ansaetze zum Verstaendnis neuropsychiatrischer Erkrankungen. In: Kasten, E., Kreutz, M. R., Sabel, B.A. (Eds.) Neuropsychologie in Forschung und Praxis: Hogrefe, Göttingen, pp. 111-124.

11. Kreutz, M.R., Boeckers, T., Weise, J., Vorwerk, C., Kasten, E. and Sabel, B.A. (1997) Mechanismen von Restitutionsprozessen im visuellen System am Beispiel der funktionellen Erholung nach retinaler Exzitotoxizitaet und kontrollierter Quetschung des Sehnerven. In: Kasten, E., Kreutz, M.R., Sabel, B.A. (Eds.) Neuropsychologie in Forschung und Praxis: Hogrefe, Göttingen, pp. 66-76.

12. Wüst, S., Rosemann, K., Kasten, E. and Sabel, B.A. (1996) Ein neues Therapiekonzept für Menschen mit zerebralen Sehstörungen. Die Gegenwart. Organ des Deutschen Blindenverbandes 3/96: pp.17-20.

13. Kasten, E., Heinze, H.-J. and Sabel, B.A. (1995) Finger, S: Origins of Neuroscience - History of Explorations into Brain Function. Book Review. Der Nervenarzt 10/95: p. 729.

14. Sabel, B.A. and Steinbüchel, N. (1994) Die Repräsentation psychischer Funktionen im Gehirn. In: Gerber, W.-D., Basler, H.-D. and Tewes, U. (Eds.) Medizinische Psychologie: Verlag Urban & Schwarzenberg, pp. 19-31.

15. Aschoff, A., Schmitt, U. and Sabel, B.A. (1994) The role of gangliosides and trophic factors in brain repair. In: Fuxe, K. Agnati, L.F., Bjelke, B. and Ottoson, D (Eds.) Trophic regulation of the basal ganglia. Focus on dopamine neurons: Elsevier Sci. Ltd., Oxford, pp. 235-249.

16. Kasten, E., Aschoff, A. and Sabel, B.A. (1993) Restitution visueller Funktionen bei Tie-ren und bei Patienten mit Hirnschäden. In: Montada, L. (Eds.) "Bericht über den 38. Kongreß der Deutschen Gesellschaft für Psychologie in Trier 1992": Hogrefe, Göttingen, pp. 235-240.

17. Sabel, B.A., Vantini, G., and Finklestein, S. (1992) The role of neurotrophic factors in the treatment of neurological disorders. In: Vecsei, L. ed. al (Eds.) Neurological Disorders: Novel Experimental and Therapeutic Strategies: Simon & Schuster, USA, pp. 114-180.

18. Sabel, B.A. and Schonecke, O. (1992) Über die Lage der medizinpsychologischen Forschung. Ein Bericht der Forschungskommission der DGMP. Mitteilungen der Deutschen Gesellschaft für Medizinische Psychologie 42: pp. 15-19.

19. Sabel, B.A. (1991) Wissenschaft und Medien: ist die Integration der Wissenschaften in Europa Mythos oder Realität. In: "Europäische Integration als Herausforderung der Kultur: Pluralismus der Kulturen oder Einheit der Bürokratien. Ein Almanach junger Kulturwissenschaftler": Hanns Martin Schleyer Stiftung, pp. 216-217.

20. Sabel, B.A. (1990) Physiologische Psychologie. In: Bullinger, M. and Pöppel, E. (Eds.) Medizinische Psychologie: VCH Verlagsgesellschaft, Weinheim, pp. 130-138.

21. Sabel, B.A. (1989) Drug discovery for the treatment of brain injury - principles, problems, perspectives. In: Hendrie, H., Mendelsohn, L. and Readhead, C. (Eds.) "Brain Ageing: Molecular Neurobiology, The Ageing Process and Neurodegenerative Diseases": Bernh, Hogrefe & Huber, pp. 127-140.

22. Sabel, B.A., Donicht, M. and Schneider, G.E. (1988) Compensatory sprouting of retino-fugal axon trees after early tectal lesions: New evidence for the principle of "conservation of total axonal arborization". In: Flohr, H. (Eds.) Post-lesion neuronal plasticity: Berlin/Heidelberg/New York, Springer, pp. 139-153.

23. Sabel, B.A. (1988) Anatomical mechanisms whereby ganglioside treatment induces brain repair: what do we really know? In: Stein, D.G. and Sabel, B.A. (Eds.) 'Pharmacological approaches to the treatment of brain and spinal cord injury': Plenum Press, New York, pp. 167-194.

24. Sabel, B.A. and Schneider, G.E. (1987). GM1 ganglioside injections increase axon sprouting in the retinotectal system of the hamster. In Rahmann, H. (Eds.) 'Gangliosides and Modulation of Neuronal Functions': Springer, Berlin/ Heidel-berg/New York, NATO ASI-Series, pp. 595-596.

25. Sabel, B.A., Dunbar, G.L., Fass, B. and Stein, D.G. (1985) Gangliosides, neuroplasticity, and behavioral recovery after brain damage. In: Will, B.E., Schmitt, P. and Dalrymple-Alford, J.C. (Eds.) Brain Plasticity, Learning and Memory: Plenum Press, pp. 481-493.

26. Ruppell, G. (1985) A 'lie' as a directed message of the Arctic Fox (Alopex lagopus L.). Translated by Sabel, B.A. and Munn, Ch.. In: Mitchell, R.W. and Thompson, N.S. (Eds.). Deception: Perspective on Human and Nonhuman Deceit. Albany: SUNY.

C. Bücher

1. Kasten, E., and Sabel, B.A. (1993) - (2006) GK1 Medizinische Psychologie/Medizinische Soziologie, Prüfungsfragen/Kommentare ("Schwarze Reihe"): VCH Verlag, edition medizin (14. Auflage).

2. Charness, N., Park, D.C. and Sabel, B.A. (Eds.) (2001) Communication, Technology and Aging: Springer Publishing corporation.

3. Freund, H.-J., Sabel, B.A. and Witte, O. (Eds.) (1997) Brain Plasticity: Lippincott/Raven Press.

4. Kasten, E., Kreutz, M.R. and Sabel, B.A. (Eds.) (1997) Grundlagenforschung in der Neuropsychologie: Goettingen: Hogrefe.

5. Domagk, G., Drechsel-Buchheidt, A., Emmig, C.T., Golenhofen, K., Kasten, E., Neufeldt-Brasche, Sabel, B.A., Schimmelmann, B., Seibt, W. and Zech, R. (1994) GK1 Herbst 1994: Chapman & Hall, Weinheim.
   
6. Domagk, G., Drechsel-Buchheidt, A., Emmig, C.T., Golenhofen, K., Kasten, E., Neufeldt-Brasche, Sabel, B.A., Schimmelmann, B., Seibt, W. and Zech, R. (1994) GK1  Herbst 1993, Frühjahr, 1994: Chapman & Hall, Weinheim.
 
7. Kasten, E., Janke, W. and Sabel, B.A. (Eds.) (1994) Medizinische und Biologische Psychologie: Könighausen & Neumann, Germany.

8. Stein, D.G. and Sabel, B.A. (Eds.) (1988) Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury: New York, Plenum Press.

D. Patente

2.  Sabel, BA. (2006) Process & Device for Training Blind Regions of the Visual Field (Turbo), US-Patent application, pending.

3.  Sabel, BA. (2006) Treatment of Retinal Diseases, US-Patent application, pending.

4.  Seal J., Bare R.O., Payne T.J.,  Smith J.C., Moulds J.A.,  Paul P.J., Kenkel S., Boster M., Sabel B.A.  (2005) Adjustable Device for Vision Training, US-Patent application, pending.   

5.  Todd D.P. and Sabel, B.A. (2005) Method and Device for Guiding a User's Head During Vision Training. US-Patent application, pending.

6.  Sabel, B. A., Kreuter, J., Gelperina, S., Schröder, U.: Use of Drug-Loaded Nanoparticles for the Treatment of Cancers; PCT/EP99/03838, (1999).

7.  Sabel, B. A., Kasten, E.: Process and Device for the Training of Human Vision, PCT/EP98/05505, (1998).

8.  Sabel, B. A., Schröder, U.: Drug Targeting System, Method of its Preparation and its Use, PCT/EP97/03099, (1997).

9.  Sabel, B.A. und Engelmann, R. (1997) Anordnung und Verfahren zur nicht-invasiven Bestimmung und/oder Erzeugung funktioneller und/order morphologischer Eigenschaften von Zellen des Auges im lebenden Organismus. Deutsche Patentanmeldung, filed.

10. Kreuter, J., Karkevich, D. A., Sabel, B. A., Alyautdin, R. N.: Drug Targeting to the Nervous System by Nanoparticles United States Patent, US 6,117,454 (1995).

11. Kreuter, J., Karkevich, D. A., Sabel, B. A., Alyautdin, R. N.: Drug Targeting System, Method for Preparing same and its Use, PCT/EP95/00724, (1995).

12. Sabel, B.A. and Freese, A. (1990). Extended drug delivery of small, water-soluble molecules.  European Patent application, 0 417 572 A2.

13. Sabel, B.A. and Freese, A. (1992). Specification of extended drug delivery of small, water-soluble molecules. United States Patent, filed under #07/043,695.

14. Sabel, B.A., Freese, A., Saltzman, W.M. and During, M.J. (1989) Specification of drug delivery to the central nervous system. United States Patent, filed under #07/407,930.

15. Sabel, B.A., Freese, A., and Saltzman, W.M. (1989).  Controlled drug delivery system for treatment of neural disorders. United States Patent #4,883,666; European Patent application, 0 290 891.

E.  Diplom und Doktorarbeiten

Sabel, B.A. 1988. Funktionelle Restitution nach Hirnläsionen im visuellen System des Hamsters (mesocricetus auratus). Habilitationsarbeit, Ludwig-Maximilians-Universität München, Medizinische Fakultät.

Sabel, B.A. 1984. The pharmacological treatment of brain damage with gangliosides: physiological and behavioral aspects. Ph.D. thesis, Clark University, Department of Psychology, Worcester, Massachusetts, USA.

Sabel, B.A. 1982. Reorganisation nigrothalamischer Faserverbindungen nach unilateraler Paralyse und sensorischer Deprivation. Diplom-Arbeit, Universität Düsseldorf, Naturwissenschaftliche Fakultät.

 F.  Abstracts von wissenschaftlichen Tagungen (seit 2002)

• Bouazzaoui, A., Singh, S., Noblejas, I., Kubasch, J., Radunz, H.-E. & Sabel, B. A. (2006) Treatment of central nervous system (CNS) diseases using non-viral delivery system. 5th Forum of European Neurosciences. Vienna, Austria. July 8-12
• Gall, C., Mueller, I., Kaufmann, C. & Sabel, B. A. (2006) Effects of long-term use of vi-sion restoration therapy (VRT) and stability of visual field improvements >3 years. 32nd Annual Meeting North American Neuro-Ophthalmology Society. Tucson, Arizona. Feb 25-March 2.
• Mueller, I. & Sabel, B. A. (2006) Vision Restoration Therapy after stroke and traumatic brain injury: A large sample retrospective study. Stroke. Kissimmee, Florida. Feb 16-18
• Mueller, I., Sabel, B. A. & Kasten, E. (2006) Comparison of early and late rehabilitation of stroke and cerebral trauma patients with visual field defects. 10th Congress of the European Federation of Neurological Societies. Glasgow, United Kingdom. Sept 2-5
• Noblejas, I., Prilloff, S. & Sabel, B. A. (2006) The dual role of calcium activation after neurotrauma: death or recovery of retinal ganglion cells in vivo depends on intracellular calcium dynamics after optic nerve crush. Neuroprotection & Neurorepair. Magdeburg, Germany. May 3-6
• Prilloff, S., Noblejas, I. & Sabel, B. A. (2006) The dual role of calcium activation after neurotrauma: death or recovery of retinal ganglion cells in vivo depends on intracellular calcium dynamics after optic nerve crush. 5th Forum of European Neurosciences. Vienna, Austria. July 8-12
• Sabel, B. A., Mast, H. & Mueller, I. (2006). Vision restoration therapy (VRT) after brain damage: retrospective analysis of visual fields in 300 patients and eye movement recordings. Deutsche Gesellschaft für Klinische Neurophysiologie und Funktionelle Bild-gebung. Bad Nauheim. March 22.-26
• Sabel, B. A., Gall, C. & Müller, I. (2006) Stability of visual field improvements 3.8 years after discontinuing vision restoration therapy (VRT). American Academy of Neurology. San Diego, California, April 1-8
• Sabel, B. A., Kasten, E., Mueller-Oehring, E. M., Bunzenthal, U., Gothe, J. & Poggel, D. A. (2006) Cognitive mechanisms and hallucinations as hallmarks of visual system plasticity in hemianopic patients during vision restoration therapy (VRT). 32nd Annual Meeting North American Neuro-Ophthalmology Society. Tucson, Arizona. Feb 25-March 2.
• Sabel, B. A. Mueller, I., Mast, H. (2006). Restoring Visual Functions after Brain Injury: a large-sample retrospective study using Vision Restoration Therapy. American Academy of Neurology. San Diego, California, April 1-8
• Singh, S., Bouazzaoui, A., Walz, C., Kubasch, J., Radunz, H.-E. & Sabel, B. A. (2006) Nanoparticles as drug delivery method to transport cytostatic agents across the blood-brain-barrier. 27. Deutscher Krebskongress. Berlin, Germany. March 22-26
• Singh, S., Ringe, K., Walz, C., Bouazzaoui, A. & Sabel, B. A. (2006) The treatment of glioblastoma with several Drug-Nanoparticle complexes. 5th Forum of European Neurosciences. Vienna, Austria. July 8-12

2005

• Ambrousi, A., Bouazzaoui, A., von Briesen, H., Kreuter, J., Kubasch, J., Radunz, H.-E., Sabel, B. A., Schwedat, A., Singh, S., Tanski, S. & Theisen, A. (2005) Entwicklung von PBCA-NP als Trägersystem zur Behandlung von Hirntumoren und für die Gen-therapie. BMBF-Symposium "Nanobiotechnologie". Hannover, Germany. Oct 18-19
• Gall, C., Müller, I., Kaufmann, C. & Sabel, B. A. (2005) Vision Restoration Therapy (VRT): Effects of long-term use and stability of visual field improvements". Stroke. New Orleans, Louisiana. May 2-4
• Gudlin, J., Müller, I. & Sabel, B. A. (2005) Test variability in glaucomatous visual fields tested with highresolution perimetry. European Conference of Visual Perception. A Coruña, Spain. Aug 22-26
• Mueller, I., Kasten, E. & Sabel, B. A. (2005) A prospective study of childhood visual system plasticity after brain damage. VISION. London, United Kingdom. April 4-7
• Sabel, B. A. (2005) Neuroscience in Germany XII. Society for Neuroscience. Washington D. C.
• Sabel, B. A., Herwig, B. & Kenkel, S. (2005) Vision Restoration Therapy (VRT): visual field expansions demonstrated by retina-stabilized perimetry. Vision. London, United Kingdom. April 4-7
• Sabel, B.A., Herwig, B., Mueller, I. (2005). Vision restoration therapy (VRT) after brain damage; retro-spective analysis of 300 patients and confirmation by retina-stabilized perimetry. North American Neuro-Ophthalmology Society Meeting. Copper Mountain, Colorado. March 12-17
• Sabel, B. A. & Müller, I. (2005) Vision Restoration Therapy (VRT) after Stroke and Brain Trauma: Retrospective analysis of 300 patients. American Congress of Rehabilita tion Medicine/American Society for Neurorehabilitation Joint Conference. Chicago, Illinois. Sept 28 - Oct 2. (Neurorehabilitation and Neural Repair 19 (4))
• Ullrich, J. C., Kasten, E. & Sabel, B. A. (2005) Reaction times for object detection in everyday-life scenes. European Conference of Visual Perception. A Coruña, Spain. Aug 22-26
• Ullrich, J., Kasten, E. & Sabel, B. A. (2005) Ergebnisse eines Tests zur visuellen Exploration bei Patienten mit Gesichtsfelddefekten und Normalprobanden im Vergleich. Gemeinsame Jahrestagung Deutsche Gesellschaft für Neurotraumatologie und Klinische Neurorehabilitation & Deutsche Gesellschaft für Neurorehabilitation. April 6-9
• Ullrich, J., Kasten, E. & Sabel, B. A. (2005) Speed of information processing, memory span and detection times. Conference of Cognitive Science. Stresa, Italy. July 21-24
• Bouazzaoui, A., Ringe, K., Kubasch, J., Singh, S., Schneider, T., Becker, A., Radunz, H.-E. & Sabel, B. A. (2006) Development of PBCA NPs as Carrier System for the Treatment of Brain Tumors and for the Gene Therapy. 27. Deutscher Krebskongress. Berlin, Germany. March 22-26

2004

• Gall C, Mueller I, Kaufmann C, Sabel B. A. (2004) Visuelle Restitutionstherapie (VRT): Effekte von Langzeittraining und Stabilität von Gesichtsfelderweiterungen nach einem trainingsfreien Intervall. 2. Interdisziplinärer LowVision-Kongress. Würzburg, Germany. Oct 1-2
• Jobke, S., Kasten, E. & Sabel, B. A. (2004) Analyse der Auswirkungen unkorrigierter Fehlsichtigkeiten auf die Performanz eines PC-Programms. Deutsche Gesellschaft für Medizinische Physik/Deutsche Gesellschaft für Massenspektometrie. Bochum, Germany. June 3-5
• Kasten, E., Mueller-Oehring, E. M., Mueller, I. & Sabel, B. A. (2004) Influence of attention on visual field training. Society for Neuroscience. San Diego, California. Oct 23-27. (No. 524.13.)
• Kenkel, S. Kasten, E. & Sabel, B. A. (2004) Sehtraining nach Gesichtsfeldausfall - subjektive visuelle Verbesserungen und Alltagsrelevanz. Gemeinsamer Kongress der Deutschen Gesellschaft für Medizinische Psychologie / Deutsche Gesellschaft für Medizinische Soziologie. Bochum, Germany. June 3-5. (In: D. Hallner, O. v. d. Knesebeck, M. Hasenbring [Hrsg.] Neue Impulse in der Medizinischen Psychologie und Medizinischen Soziologie. Lengerich: Pabst Science Publishers: 106)
• Mueller I, Gall C, Kasten E, Sabel B. A. (2004). Long-term stimulation of residual function in patients with visual field defects after post-chiasmatic lesions. 77. Kongress der Deutschen Gesellschaft für Neurologie. Düsseldorf, Germany. Oct 6-9
  Mueller, I., Kasten, E. & Sabel, B. A. (2004) Vision restoration therapy in children with visual field defects. Society for Neuroscience. San Diego, California. Oct 23-27. (No. 524.14.)
• Mueller, I., Kasten, E. & Sabel, B. A. (2004) Visual restoration training beyond 6 months further increases size of visual field in patients with Postchiasmatic Lesions. 29th International Stroke Conference. San Diego, California. Feb 5-7
• Ringe, K., Walz, C. M., Balan, K. & Sabel, B. A. (2004) Drug and Gene Delivery to the brain with Nanoparticles. 3rd Annual BCC Conference "Nanotech and Biotech Con-vergence". Cambridge, Massachusetts. May 28-30
• Sabel, B. A. (2004) Neuroscience in Germany XI. Society for Neuroscience. San Diego, California. Oct 23-27
• Sabel, B. A., Kenkel, S., Kasten, E. & Mueller, I. (2004) Vision Restoration Therapy (VRT)  for the treatment of visual field deficits after brain damage: the role of eye movements and fixation behavior. Cortical Vision Fall Meeting. Rochester, NY. Oct 28-29. (In: Journal of Vision 2005. Volume 4, Number 11, Abstract 29: 29a)
• Studer, T., Kasten, E., Kenkel, S. & Sabel, B. A. (2004) Vergleich dreier perimetrischer Verfahren zur  Diagnostik von Gesichtsfelddefekten und deren Restitution. Gemeinsamer Kongress der Deutschen Gesellschaft für Medizinische Psychologie / Deutsche Gesellschaft für Medizinische Soziologie. Bochum, Germany. June 3-5. (In: D. Hallner, O. v. d. Knesebeck, M. Hasenbring [Hrsg.] Neue Impulse in der Medizinischen Psychologie und Medizinischen Soziologie. Lengerich: Pabst  Science Publishers: 107)
• Ullrich, J., Kasten, E. & Sabel, B. A. (2004) Development of an object detection test for patients with visual field defects. 4th Forum of European Neurosciences. Lisbon, Portugal. July 10-14
• Ullrich, J., Kasten, E. & Sabel, B. (2004) Impact of visual field defects on activities of daily living. Second Scientific Conference 'Restauración Neurológica'. Havanna, Cuba. Feb 24-27. (Restorative Neurology and Neuroscience, Special Issue, 21)
• Ullrich, J., Kasten, E. & Sabel, B. (2004) Durch Gesichtsfeldausfälle bedingte Alltagsprobleme. Gemeinsamer Kongress der Deutschen Gesellschaft für Medizinische Psychologie / Deutsche Gesellschaft für Medizinische Soziologie.  Bochum, Germany. June 3-5. (In: D. Hallner, O. v. d. Knesebeck, M. Hasenbring [Hrsg.] Neue Impulse in der Medizinischen Psychologie und Medizinischen Soziologie. Lengerich: Pabst Science Publishers: 105)

2003

• Arnold, M., Mueller-Oehring, E. M., Kasten, E. & Sabel, B. A. (2003) Visual restitution in visuo-spatial neglect - a single case study. 26th Annual International Neuro psychological Society Mid-Year Con-ference. Berlin, Germany. July 16-20. (JINS 9 (4): 544)
• Kasten, E., Mueller-Oehring, E. M., Mueller, I. & Sabel, B. A.(2003) Optimization of visual field training with systematic co-stimulation. 33rd Annual Meeting Society for Neuroscience. New Orleans, Louisiana. Nov 8-12. (No. 818.19.)
• Kasten, E., Mueller, I., Sabel, B. A. (2003). Improvement of Visual Function in Patients with Visual Field Defects. 26th Annual International Neuropsychological Society  Mid-Year Conference. Berlin, Germany. July 16-20. (JINS 9 (4): 510)
• Kreuter, J., Ambrousi, A., Tanski, S., Kock, M., Theisen, A., von Briesen, H., Ringe, K., Walz, C. M. & Sabel, B. A. (2003) Funktionale Systeme auf Nanopartikel-Basis zur Behandlung von Gehirn-Tumoren. Hannover, Germany. Oct 8-9
• Kuelzow, N., Mueller, I. & Sabel B. A. (2003). Reaction times and probability of stimulus detection in areas of residual vision after brain damage. Fechner Day. Larnaca, Cyprus. (In B. Berglund and E. Borg [Ed.], Fechner Day 2003. Proceedings of the ninetieth annual meeting of the International Society for Psychophysics: 145-150. Stock-holm: International Society for Psychophysics)
• Mueller, I. & Sabel, B. A. (2003) Vision Training after brain damage. 26th Annual International Neuropsychological Society Mid-Year Conference. Berlin, Germany. July 16-20. (JINS 9 (4): 510
• Mueller, I., Poggel, D. A., Kasten, E. & Sabel, B. A. (2003) Visuelles Restitutionstraining (VRT) zur Behandlung von Gesichtsfeldausfällen nach Schlaganfall. Deutsche Gesellschaft für Neurorehabilitation. Weimar, Germany. Nov 21-29. (Neurol Rehabil 9 (6))
• Mueller, I., Kasten, E., Sabel, B.A. (2003). Identifying Training Potential in Patients with Visual Field Defects. 26th Annual International Neuropsychological Society Mid-Year Conference. Berlin, Germany. July 16-20. (JINS 9 (4): 510)
• Mueller, I., Sabel, B.A. (2003). Predictors of training success in visual restitution therapy- a retrospective study. 23rd European Winter Conference on brain research. Arc. March 8-15
• Poggel, D. A., Mueller-Oehring, E. M., Gothe, J., Kenkel, S., Kasten, E. & Sabel, B. A. (2003) Patients with visual field defects experience pseudo-hallucinations during spontaneous and training-induced recovery. ARVO Annual Meeting
• Poggel, D. A., Mueller-Oehring, E. M., Gothe, J., Kasten, E., Kenkel, S. & Sabel, B. A. (2003) Pseudohalluzinationen während spontaner und trainingsbedingter Verbesserung von Sehleistungen bei Patienten mit Hirnschädigungen. 6. Tübinger Wahrneh-mungskonferenz. Tübingen, Germany. Feb 21-23
• Sabel, B. (2003) Neuroscience in Germany X. 33rd Annual Meeting Society for Neuroscieence. New Orleans, Louisiana. Nov 8-12.
• Schadow, J., Naue, N., Herrmann, C. S., Sabel, B. A. & Paramei, G. (2003) Gestalt Perception in hemianopic patients: performance measures and Veps. Fechner Day. Larnaca, Cyprus. (In B. Berglund and E. Borg [Ed.], Fechner Day 2003. Proceedings of the ninetieth annual meeting of the International Society for Psychophysics. Stockholm: International Society for Psychophysics)
• Toepfer, A., Kasten, E. & Sabel, B. A. (2003) The swinging fixation point in high-resolution campimetry of visual field defects. 33rd Annual Meeting Society for Neuroscience. New Orleans, Louisiana. Nov 8-12. (No. 386.17.)
• Walz, C. M., Ringe, K. & Sabel, B. A. (2003) Nanoparticles in brain tumor therapy. 30th Annual Meeting Controlled Release Society. Glasgow, Scotland. July 19-23

2002

• Arnold, M., Mueller-Oehring, E. M., Kasten, E. & Sabel, B. A. (2002) Effektivität und Vergleich konzeptuell verschiedener Ansätze zur computergestützten Behandlung des visuellen Neglects im häuslichen Bereich des Patienten. 14. Kongress der Deutschen Gesellschaft für Medizinische Psychologie. Dresden, Germany. May 23-25. (In: F. Balck, H. Berth & A. Dinkel [Hrsg.] medizinpsychologie.com - State of the Art der Medizinischen Psychologie. Lengerich: Pabst-Verlag: 13-14)
• Kasten, E., Kenkel, S., Mueller-Oehring, E. M., Mueller, I. & Sabel, B. A. (2002) Computer-based restitution training of visual field defects in patients. 32nd Annual Meeting Society for Neuroscience. Orlando, Florida. Nov 2-7. (760.4.Washington, DC: Society for Neuroscience)
• Kasten, E., Kenkel, S., Schreiber, A., Reinhard, J., Trauzettel-Klosinski, S., Connert, C. & Sabel, B. A. (2002) Visual Restitution Training (VRT) in patients with homonymous field defects: Evaluation with repeated static, high-resolution suprathreshold campimetry using the NovaVision Status Program. Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Fort Lauderdale, Florida. May 5-10
• Kenkel, S., Mueller, I., Kasten, E., Sabel, B. A. (2002). Restoration of vision IV: visual restitution training (VRT) improves every day activities and subjective vision as assessed by patient report. 3rd World Congress of Neurological Rehabilitation. Venice, Italy. April 2-6
• Mueller, I., Poggel, D. A., Kasten, E. & Sabel, B. A. (2002) Predicting the outcome of visual restitution training: a retrospective clinical study on visual system plasticity. 32nd Annual Meeting Society for Neuroscience. Orlando, Florida. Nov 2-7. No. 760.5. 2002
• Mueller, I., Kasten, E., Sabel, B.A. (2002). Restoration of Vision III: Predictive variables of visual restitution therapy and training in children. 3rd World Congress of Neurological Rehabilitation. Venice, Italy. April 2-6
• Mueller-Oehring, E. M., Schulte, T., Kasten, E. & Sabel, B. A. (2002) Distractor dependent visual search performance in patients with neglect and hemianopia. 32nd Annual Meeting Society for Neuroscience. Orlando, Florida. Nov 2-7. (No. 476.13. Washington, DC: Society for Neuroscience, 2002. Online)
• Poggel, D. A., Mueller-Oehring, E. M., Kasten, E., Bunzenthal, U. & Sabel, B. A. (2002) Training-induced patterns of visual-field recovery: changes of objective and subject tive visual-field size in brain-lesioned patients. European Conference of Visual Perception. Glasgow, Scotland
• Poggel, D. A., Mueller-Oehring, E. M., Kasten, E., Bunzenthal, U. & Sabel, B. A. (2002) Topographische Muster der Gesichtsfelderweiterung: Veränderung objektiver und subjektiver Gesichtsfeldgröße im Verlauf eines Restitutionstrainings. 5. Tübinger Wahrnehmungskonferenz. Tübingen, Germany. Feb 22-24
• Poggel, D. A., Mueller-Oehring, E. M., Kasten, E., Bunzenthal, U. & Sabel, B. A. (2002) Patterns of visual field recovery: Decrease of defect size in perimetry and of subjecttive scotoma size in patients with cerebral lesions performing visual restitution training. Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Fort Lauderdale, Florida. May 5-10
• Poggel, D., Kasten, E. & Sabel, B. A. (2002) Restoration of vision II: Attention improves visual restitution training (VRT) in brain-damaged patients. 3rd World Congress in Neurological Rehabilitation. Venice, Italy. April 2-6. (Venice, Abstract-Book p. 189)
• Reinhard, J., Trauzettel-Klosinski, S., Schreiber, A., Rettenmaier, D., Sabel, B. A., Kasten, E., Kenkel, S. & Schiefer, U. (2002) Visual Restitution Training (VRT) in Patients with homonymous field defects: Evaluation with fundus-controlled perimetry using the SLO. Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Fort Lauderdale, Florida. May 5-10
• Rohatgi, T., Sedehizade, F., Sabel, B. A. & Reiser, G. (2002) Protease-activated receptors (PARS) mRNA-expression in the retina after optic nerve crush in developing and adult rat. Society for Neuroscience. Orlando, Florida. Nov 2-7. (No. 843.28. 2002)
• Rohatgi, T., Sedehizade, F. & Sabel, B. A.(2002) mRNA-expression pattern of protease-activated receptors (pars) in the retina and optic nerve after optic nerve crush in the adult rat. Forum of European Neurosciences. July 13-17
• Sabel, B. A., Mueller, I., Kenkel, S. & Kasten, E. (2002) Visuelles Restitutions Training (VRT) in Patienten mit homonymen Gesichtsfelddefekten:subjektive Sehleistungssteigerung und deren Beziehung zu örtlichen und zeitlichen Parametern des visuellen Verarbeitung. 9. Tagung der Bielschowsky-Gesellschaft. Heidelberg, Germany. Nov 8-10
• Sabel, B. A., Kenkel, S., Schreiber, A., Schiefer, U., Reinhard, J., Trauzettel-Klosinski, S., Connert, C. & Kasten, E. (2002) Visual Restitution Training (VRT) in Patients with homonymous field defects: Improvements of subjective vision and their relation to reaction time, visual field enlargements and exe movements. Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Fort Lauderdale, Florida. May 5-10.Mai
• Schreiber, A., Vonthein, R., Reinhard, J., Trauzettel-Klosinski, S., Sabel, B. A., Kasten, E., Kenkel, S., Connert, C. & Schiefer, U. (2002) Visual Restitution Training (VRT) in Patients with homonymous field defects: Evaluation with static suprathreshold automated perimetry by using Tuebingen Automated Perimeter (TAP). Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Fort Lauderdale, Florida. May 5-10
• Schreiber, A., Vonthein, R., Reinhard, J., Trauzettel-Klosinski, S., Sabel, B. A., Kasten, E., Connert, C. & Schiefer, U. (2002) Evaluation des NovaVision Visual Restitutions Training (VRT) bei Patienten mit homonymer Hemianopsie: Untersuchungsbefunde am Tübinger Automatik Perimeter (TAP 30°). 9. Tagung der Bielschowsky-Gesellschaft. Heidelberg, Germany. Nov 8-10
• Töpfer, A., Kasten, E. & Sabel, B. A. (2002) Verbesserung der Patientencompliance bei perimetrischen Untersuchungen durch einen bewegten Fixationspunkt. 14. Kongress der Deutschen Gesellschaft für Medizinische Psychologie. Dresden, Germany. May 23-25. (In: F. Balck, H. Berth & A. Dinkel [Hrsg.] medizinpsychologie.com - State of the Art der Medizinischen Psychologie. Lengerich: Pabst-Verlag: 143-144)
• Ullrich, J., Mueller-Oehring, E., Mueller, I., Kenkel, S., Arnold, M. Kasten, E. & Sabel, B. A. (2002) Beeinträchtigungen im Alltag bei Gesichtsfelddefekten. 43. Kongress der Deutschen Gesellschaft für Psychologie. Humboldt-Universität zu Berlin. Berlin, Germany. Sept 22-26
• Walz, C. M., Ringe, K. & Sabel, B. A. (2002) Nanoparticles in brain tumor therapy. 2nd International Symposium on Tumor Targeted Delivery Systems. Rockville, Maryland. Sept 22-25

G.  Vorträge (seit 2002)

2006

• Johns Hopkins University, Wilmer Eye Institutes, Baltimore, USA, Neurology Grand Rounds
• University of Kentucky Neurology Department, Louisville, USA, Neurology Grand Rounds
• American Academy of Neurology (AAN), San Diego, USA, Congress Platform Presentation
• North-American Neuro-Ophthal Society (NANOS), Tucson USA, Platform Presentation
• Klinikum Rotenburg an der Fulda, Neurologisches Symposium, Invited presentation
• International Society for Neuropsychology, Invited presentation and Sympsium chairman

2005

• University College London, Dept. of Ophthalmology, London, UK, Invited lecture
• City University of London, Dept. of Neuroscience, London, UK, Invited lectur
• Emory University Med. School, Dept. Rehabilitation Medicine, Atlanta, USA, Invited lecture
• Emory Eye Clinic, Dept. of Neuro-Ophthalmology, Atlanta, USA, Invited lecture
• Klinik Berlin, Neurologische Rehabilitation, (Prof. Mauritz), Charité, Invited lecture
• University of Miami, Dept. of Neurology, Miami, USA, Invited lecture
• Bascom Palmer Eye Institute, Dept. of Neurosurgery, Miami, USA, Invited lecture
• North-American Neuro-Ophthal. Society (NANOS), Copper Mnt USA, Platform presentation
• University of Magdeburg; Presentation at a delegation from the Peoples Republic of China
• Essilor S.p.a., Paris, France, Invited lecture
• VISION 2005, London, UK, Congress lecture and chairmanship
• The Institutes for the Achievement of Human Potential, Philadelphia, USA, Invited lecture
• University of Münster, Dept. Ophthalmology, Münster, Germany, Invited lecture
• Humboldt University (Charité), Dept. of Ophthalmology, Berlin, Germany
• Bosenberg Clinic, St. Wendel, Germany, Invited lecture
• "BioThailand" Intern. Conf. on BioNanotechnol., Bangkok, Thailand, Platform presentation
• "Brain Week, Science & Cité" (Prof. Büttner), Aarau, Switzerland, Invited lecture
• University of Jena; Workshop "Molecular Imaging & Magnetic Nanoparticles, Invited lecture

2004

• Low Vision Conference, Würzburg, Germany, Congress presentation
• The Schepens Eye Institute, Harvard Medical School, Boston, USA, Invited lecture
• The Massachusetts Eye and Ear Inst., Harvard Medical School, Boston, USA, Invited lecture
• German Society for Neuropsychology (GNP),  München, Germany, Congress presentation
• Fall Vision Meeting, University of Rochester, Rochester, USA, Congress presentation
• Low Vision Meeting, Zürich, Switzerland, Congress presentation
• Augenärztliche Akademie, Düsseldorf, Germany, Congress presentation
• Dept. Physiology, Physiological Colloquium, University of Hamburg, Invited lecture
• Rehabilitationsklinik Lingen, Lingen, Germany, Invited lecture
• Rehabilitationsklinik Rheinfelden, Rheinfelden, Switzerland, Invited lecture
• International Conference for Neurorehabilitation, Zürich, Switzerland, Congress presentation
• Tan Tock Seng Hospital, Dept. of Ophthalmology, Singapore, Invited lecture
• International Society for Neuro-Ophthalmology, Geneva, Switzerland, Congress presentation

2003

• University of Peking, Department of Psychology, People´s Republic of China, Invited lecture
• University of Düsseldorf, Dept. of Psychology, Germany, Invited lecture
• Emory Eye Clinic, Atlanta, Georgia, Invited lecture
• Internatl & German Society for Neuropsychology, Berlin, Germany, Congress presentation
• EMN-Meeting, Graz, Austria, Congress presentation
• DGNKN, Hannover, Germany, Congress presentation
• HEC GmbH, Bremen, Invited lecture
• NovaVision Inc., Boca Raton, USA, Invited lecture
• Annual Congress of the WVAO, Nürnberg, Germany, Congress lecture
• Wolfsburg AG, Wolfsburg, Germany, Invited lecture
• Graduiertenkolleg Univ. Magdeburg, Germany, Invited lecture
• Reha-Klinik Reichshof Eggeshagen, Germany, Invited lecture
• Rehamed, Stuttgart, Germany, Invited lecture
• Klinik Valenz, Valenz, Switzerland, Invited lecture
• European Winter Conference on Brain Research, Les Arc, France, Congress lecture
• Blindenförderungswerk Halle, Germany, Invited lecture

2002

• European Conference on Telemedicine, Luxembourg, Congress presentation
• World Congress of Neurological Rehabilitation,Venice, Italy, Congress presentation
• Bilschowski Meeting, University of Heidelberg, Germany, Congress presentation
• Bascom Palmer Eye Institute, Dept. of Neurology, Miami, USA, Invited lecture
• University of Miami, Dept. of Neurology, Miami, USA, Invited lecture
• RODIN lecture series, Inst. Med. Psychology., University Munich, Germany, Congress presentation